Ruimei is a Swiss–China regenerative medicine and bioscience company developing human collagen, extracellular vesicle, medical-aesthetic and cosmeceutical platforms. Our purpose is to make advanced science understandable, responsible and relevant to real products.
Tissue Regeneration Laboratory established to connect biomaterial research with product development.
Lausanne, Switzerland, and Shenzhen, China—connecting scientific perspective with laboratory development and translation.
RégénéColla™ human collagen and RegeneExo™ extracellular vesicles—the two technologies at the centre of Ruimei’s research.
GMP-aligned systems and ISO Class 7 cleanroom capability support controlled development and lot-specific quality review.
In 2023, Ruimei established its Tissue Regeneration Laboratory around a clear belief: regenerative science should work with biological structure and be communicated with precision. RégénéColla™ human collagen and RegeneExo™ extracellular vesicles became the two core technology platforms through which that belief is explored.
Our presence at EPFL Innovation Park places Ruimei within Lausanne’s life-science environment. The Swiss centre contributes to scientific strategy, biomaterial research and international perspective, while Ruimei’s own team directs the company’s development programmes.
Our Shenzhen base integrates laboratory development, process engineering, quality coordination and product translation. It turns scientific concepts into consistent materials and product platforms across medical aesthetics, cosmeceuticals, human collagen and extracellular vesicles.
"Treatments that feel refined, look natural, and are engineered for long-term skin health."
HAVE A QUESTION ABOUT RUIMEI, OUR PRODUCTS OR OUR TECHNOLOGIES? LEAVE YOUR DETAILS AND OUR TEAM WILL RESPOND.